Missed clinical opportunities: Provider recommendations for HPV vaccination for 11-12 year old girls are limited

Vaccine

Volumn 29, Issue 47, 2011, Pages 8634-8641

  Vadaparampil, Susan T ^a   Kahn, Jessica A ^b   Salmon, Daniel ^c   Lee, Ji Hyun ^a   Quinn, Gwendolyn P ^a   Roetzheim, Richard ^d   Bruder, Karen ^d   Malo, Teri L ^a   Proveaux, Tina ^e   Zhao, Xiuhua ^a   Halsey, Neal ^e   Giuliano, Anna R ^a  

^a H LEE MOFFITT CANCER CENTER AND RESEARCH INSTITUTE   (United States)

^b CINCINNATI CHILDREN'S HOSPITAL MEDICAL CENTER   (United States)

^c U S DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

^d UNIVERSITY OF SOUTH FLORIDA   (United States)

^e JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

Author keywords

Cancer vaccine; Cervix cancer; HPV vaccine; Human papillomavirus; Physician

Indexed keywords

WART VIRUS VACCINE;

ADULT; AGE; ARTICLE; CLINICAL PRACTICE; DEMOGRAPHY; DRUG USE; FEMALE; HUMAN; MALE; MEDICAL DECISION MAKING; NORMAL HUMAN; PAPILLOMAVIRUS INFECTION; PRIORITY JOURNAL; VACCINATION;

ADOLESCENT; ADULT; ATTITUDE OF HEALTH PERSONNEL; CHILD; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS; MALE; MIDDLE AGED; PAPILLOMAVIRUS INFECTIONS; PAPILLOMAVIRUS VACCINES; QUESTIONNAIRES; UNITED STATES; UTERINE CERVICAL NEOPLASMS; VACCINATION; YOUNG ADULT;

EID: 82455192694     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2011.09.006     Document Type: Article

References (46)

1. Markowitz L.E., Dunne E.F., Saraiya M., Lawson H.W., Chesson H., Unger E.R. Quadrivalent human papillomavirus vaccine: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep 2007, 56(RR-2):1-24.
2. Centers for Disease Control and Prevention FDA licensure of bivalent human papillomavirus vaccine (HPV2, cervarix) for use in females and updated HPV vaccination recommendations from the advisory committee on immunization practices (ACIP). MMWR Morb Mortal Wkly Rep 2010, 59(20):626-629.
3. Centers for Disease Control and Prevention National, state, and local area vaccination coverage among adolescents aged 13-17 years - United States, 2009. MMWR Morb Mortal Wkly Rep 2010, 59(32):1018-1023.
4. Wong C., Berkowitz Z., Dorell C., Price R.A., Lee J.W., Saraiya M. National HPV vaccine uptake among girls 9-17 years old - National Health Interview Survey, United States, 2008. Paper presented at: American academy of pediatrics national conference & exhibition 2010.
5. Dempsey A.F., Zimet G.D., Davis R.L., Koutsky L. Factors that are associated with parental acceptance of human papillomavirus vaccines: a randomized intervention study of written information about HPV. Pediatrics 2006, 117(5):1486-1493.
6. Constantine N.A., Jerman P. Acceptance of human papillomavirus vaccination among Californian parents of daughters: a representative statewide analysis. J Adolesc Health 2007, 40(2):108-115.
7. Olshen E., Woods E.R., Austin S.B., Luskin M., Bauchner H. Parental acceptance of the human papillomavirus vaccine. J Adolesc Health 2005, 37(3):248-251.
8. Conroy K., Rosenthal S.L., Zimet G.D., Jin Y., Bernstein D.I., Glynn S., et al. Human papillomavirus vaccine uptake, predictors of vaccination, and self-reported barriers to vaccination. J Womens Health 2009, 18(10):1679-1686.
9. Daley M.F., Crane L.A., Chandramouli V., Beaty B.L., Barrow J., Allred N., et al. Influenza among healthy young children: changes in parental attitudes and predictors of immunization during the 2003 to 2004 influenza season. Pediatrics 2006, 117(2):e268-e277.
10. Gnanasekaran S.K., Finkelstein J.A., Hohman K., O'Brien M., Kruskal B., Lieu T. Parental perspectives on influenza vaccination among children with asthma. Public Health Rep 2006, 121(2):181-188.
11. Lin C.J., Zimmerman R.K., Nowalk M.P., Ko F.S., Raymund M., Hoberman A., et al. Parental perspectives on influenza vaccination of children with chronic medical conditions. J Natl Med Assoc 2006, 98(2):148-153.
12. Gamble H.L., Klosky J.L., Parra G.R., Randolph M.E. Factors influencing familial decision-making regarding human papillomavirus vaccination. J Pediatr Psychol 2009, 35(7):704-715.
13. Bovier P.A., Chamot E., Bouvier Gallacchi M., Loutan L. Importance of patients' perceptions and general practitioners' recommendations in understanding missed opportunities for immunisations in Swiss adults. Vaccine 2001, 19(32):4760-4767.
14. Brewer N.T., Hallman W.K. Subjective and objective risk as predictors of influenza vaccination during the vaccine shortage of 2004-2005. Clin Infect Dis 2006, 43(11):1379-1386.
15. Daniels N.A., Gouveia S., Null D., Gildengorin G.L., Winston C.A. Acceptance of pneumococcal vaccine under standing orders by race and ethnicity. J Natl Med Assoc 2006, 98(7):1089-1094.
16. Nichol K.L., Mac Donald R., Hauge M. Factors associated with influenza and pneumococcal vaccination behavior among high-risk adults. J Gen Intern Med 1996, 11(11):673-677.
17. Samoff E., Dunn A., VanDevanter N., Blank S., Weisfuse I.B. Predictors of acceptance of hepatitis B vaccination in an urban sexually transmitted diseases clinic. Sex Transm Dis 2004, 31(7):415-420.
18. Zimmerman R.K., Tabbarah M., Nowalk M.P., Raymund M., Jewell I.K., Block B., et al. Predictors of pneumococcal polysaccharide vaccination among patients at three inner-city neighborhood health centers. Am J Geriatr Pharmacother 2005, 3(3):149-159.
19. Rosenthal S.L., Weiss T.W., Zimet G.D., Ma L., Good M.B., Vichnin M.D. Predictors of HPV vaccine uptake among women aged 19-26: importance of a physician's recommendation. Vaccine 2011, 29(5):890-895.
20. Fernandez M.E., Allen J.D., Mistry R., Kahn J.A. Integrating clinical, community, and policy perspectives on human papillomavirus vaccination. Annu Rev Public Health 2010, 31:235-252.
21. Winer R.L., Feng Q., Hughes J.P., O'Reilly S., Kiviat N.B., Koutsky L.A. Risk of female human papillomavirus acquisition associated with first male sex partner. J Infect Dis 2008, 197(2):279-282.
22. Riedesel J.M., Rosenthal S.L., Zimet G.D., Bernstein D.I., Huang B., Lan D., et al. Attitudes about human papillomavirus vaccine among family physicians. J Pediatr Adolesc Gynecol 2005, 18(6):391-398.
23. Daley M.F., Liddon N., Crane L.A., Beaty B.L., Barrow J., Babbel C., et al. A national survey of pediatrician knowledge and attitudes regarding human papillomavirus vaccination. Pediatrics 2006, 118(6):2280-2289.
24. Raley J.C., Followwill K.A., Zimet G.D., Ault K.A. Gynecologists' attitudes regarding human papilloma virus vaccination: a survey of Fellows of the American College of Obstetricians and Gynecologists. Infect Dis Obstet Gynecol 2004, 12(3-4):127-133.
25. Freed G.L., Nahra T.A., Wheeler J.R. Counting physicians: inconsistencies in a commonly used source for workforce analysis. Acad Med 2006, 81(9):847-852.
26. Jaen C.R., Stange K.C., Nutting P.A. Competing demands of primary care: a model for the delivery of clinical preventive services. J Fam Pract 1994, 38(2):166-171.
27. Kahn J.A., Zimet G.D., Bernstein D.I., Riedesel J.M., Lan D., Huang B., et al. Pediatricians' intention to administer human papillomavirus vaccine: the role of practice characteristics, knowledge, and attitudes. J Adolesc Health 2005, 37(6):502-510.
28. Kahn J.A., Rosenthal S.L., Tissot A.M., Bernstein D.I., Wetzel C., Zimet G.D. Factors influencing pediatricians' intention to recommend human papillomavirus vaccines. Ambul Pediatr 2007, 7(5):367-373.
29. Dillman D.A. Mail and internet surveys: the tailored design method 2000, Wiley, New York.
30. Kahn J.A., Cooper H.P., Vadaparampil S.T., Pence B.C., Weinberg A.D., LoCoco S.J., et al. Human papillomavirus vaccine recommendations and agreement with mandated human papillomavirus vaccination for 11-to-12-year-old girls: a statewide survey of Texas physicians. Cancer Epidemiol Biomarkers Prev 2009, 18(8):2325-2332.
31. McCave E.L. Influential factors in HPV vaccination uptake among providers in four states. J Community Health 2010, 35(6):645-652.
32. Mao C., Koutsky L.A., Ault K.A., Wheeler C.M., Brown D.R., Wiley D.J., et al. Efficacy of human papillomavirus-16 vaccine to prevent cervical intraepithelial neoplasia: a randomized controlled trial. Obstet Gynecol 2006, 107(1):18-27.
33. Eaton D.K., Kann L., Kinchen S., Shanklin S., Harris W.A., Lowry R., et al. Youth risk behavior surveillance - United States, 2009. MMWR Surveill Summ 2010, 59(5):1-142.
34. Rand C.M., Shone L.P., Albertin C., Auinger P., Klein J.D., Szilagyi P.G. National health care visit patterns of adolescents: implications for delivery of new adolescent vaccines. Arch Pediatr Adolesc Med 2007, 161(3):252-259.
35. American Academy of Pediatrics Committee on Infectious Diseases Prevention of human papillomavirus infection: provisional recommendations for immunization of girls and women with quadrivalent human papillomavirus vaccine. Pediatrics 2007, 120(3):666-668.
36. American Academy of Family Physicians. AAFP policy statement regarding consideration of the mandated use of HPV for school attendance. ; 2007 [accessed 23.06.10]. http://www.aafp.org/online/en/home/clinical/immunizationres/mandatedhpv.html.
37. Committee on Adolescent Health Care Committee opinion no. 467: human papillomavirus vaccination. Obstet Gynecol 2010, 116(3):800-803.
38. Dempsey A., Cohn L., Dalton V., Ruffin M. Patient and clinic factors associated with adolescent human papillomavirus vaccine utilization within a university-based health system. Vaccine 2010, 28(4):989-995.
39. National Cancer Institute. Cancer health disparities. ; 2008 [accessed 29.07.10]. http://www.cancer.gov/cancertopics/factsheet/disparities/cancer-health-disparities.
40. Komaromy M., Grumbach K., Drake M., Vranizan K., Lurie N., Keane D., et al. The role of black and Hispanic physicians in providing health care for underserved populations. N Engl J Med 1996, 334(20):1305-1310.
41. Daley M.F., Crane L.A., Markowitz L.E., Black S.R., Beaty B.L., Barrow J., et al. Human papillomavirus vaccination practices: a survey of US physicians 18 months after licensure. Pediatrics 2010, 126(3):425-433.
42. Davis M.M., Ndiaye S.M., Freed G.L., Kim C.S., Clark S.J. Influence of insurance status and vaccine cost on physicians' administration of pneumococcal conjugate vaccine. Pediatrics 2003, 112(3 Pt 1):521-526.
43. Centers for Disease Control and Prevention. Vaccines for Children Program (VFC). ; 2010 [accessed 23.01.07]. http://www.cdc.gov/vaccines/programs/vfc/default.htm.
44. U.S. Food and Drug Administration. FDA approves new indication for Gardasil to prevent genital warts in men and boys. ; 2009 [accessed 17.08.11]. http://www.fda.gov/NewsEvents/Newsroom/PressAnnouncements/ucm187003.htm.
45. Weiss T.W., Zimet G.D., Rosenthal S.L., Brenneman S.K., Klein J.D. Human papillomavirus vaccination of males: attitudes and perceptions of physicians who vaccinate females. J Adolesc Health 2010, 47(1):3-11.
46. Kenward K. The scope of the data available in the AMA's Physician Masterfile. Am J Public Health 1996, 86(10):1481-1482.